The novel aspect of this invention is that it is a unique formulation of naturally occurring compounds with a unique intention to assist the concerns associated with autoimmune conditions, mainly inflammatory bowel disease (collectively Crohns, ulcerative colitis, irritable bowel syndrome), Type 1 diabetes, Multiple sclerosis, Psoriasis and the suspected infection of the pathogen Mycobacterium avium sub-species paratuberculosis (MAP). Furthermore, its intent is to address the lack of treatment options available for those with aforementioned autoimmune conditions. Specifically, to offer an alternative option that does not pose the amount of negative side effects that may be associated with contemporary treatment methods. The invention will offer a treatment method that is lower in cost as persons with autoimmune conditions conventional treatment methods costs are rising even under most insurance providers coverage. In addition, the invention offers an available method without the barriers to care most people with autoimmune conditions may encounter. The invention will provide educational information to persons with autoimmune conditions to offer an individual choice in methods of treatment. The invention will offer persons with autoimmune conditions a variety of options as said invention can be utilized con-currently with conventional treatment methods.
